CANNES LIONS 2026: WHAT HEALTH BRANDS NEED TO MAKE IMPOSSIBLE TO IGNORE 

By Katie McMorran, Group Managing Director

Cannes Lions is always full of noise. This year, what cut through was simpler, and sharper, than ever. 

Across conversations, judging rooms and standout work, one idea kept surfacing: success isn’t about what your brand says. It’s about what it evokes.   

And in health, that shift is raising the bar. 

1. From meaning to memory

The most effective brands at Cannes weren’t explaining themselves - they were felt

The work that won wasn’t just technically strong or strategically sound. It was memorable. It stayed with people, resurfacing in culture, not just campaigns.  

For healthcare brands, this marks a critical shift. Clinical clarity is still essential but it’s no longer enough. If a message doesn’t move people, it won’t move outcomes. 

2. Creativity is being judged differently

Health and pharma creativity is no longer evaluated in isolation. It’s being held up against the very best work in the world. And that changes the standard. 

The ideas that stood out combined rigour with boldness: not safe interpretations of data, but work willing to push boundaries, challenge conventions and deliver real-world impact.   

This wasn’t about being louder. It was about being bolder, while maintaining the credibility our category demands. 

3. Culture is the new battleground

Another consistent thread: the most powerful health ideas don’t interrupt culture, they embed within it. 

We saw this in both awarded work and industry conversations, where cultural fluency and partnership were highlighted as key drivers of impact - turning awareness into action by meeting people where they already are.  

For health brands, that means shifting from campaigns about audiences to ideas that exist within their world. Ideas designed to travel, be shared, and be remembered. 

What this means for health brands

If there’s one takeaway from Cannes Lions 2026, it’s this: Creativity is no longer a differentiator in health, it’s the baseline. Impact is the differentiator. 

The future belongs to work that can do all three: 

  • Earn attention in a crowded cultural landscape 

  • Build trust in high-stakes, regulated environments 

  • Drive behaviour change in the real world 

As the industry moves forward, the question for health brands isn’t whether to be bold. It’s whether they’re bold enough because if it doesn’t shift behaviour, it isn’t creative enough. 

We call this Intelligent Creativity. Unlocking the real, commercial value of our client’s science, to make sure the brilliance from the lab lands in the real world. 

Get in touch to find out more: www.saatchihealth.co.uk

Next
Next

MATT MCNALLY ON THE FUTURE OF HEALTH AT CANNES LIONS ADWEEK HOUSE